Observations placeholder
Norditropin
Identifier
019702
Type of Spiritual Experience
Background
A description of the experience
Growth hormone treatment refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. GH is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.
A small but controlled study of GH given to severely ill adults in an intensive care unit setting for the purpose of increasing strength and reducing the muscle wasting of critical illness [sic] showed a higher mortality rate for the patients having received GH.
GH is now rarely used in ICU patients unless they have severe growth hormone deficiency.
GH treatment usually decreases insulin sensitivity but some studies showed no evidence for increased diabetes incidence in GH-treated adult hypopituitary patients
In past it was believed that GH treatment could increase the cancer risk; a large study recently concluded that "With relatively short follow-up, the overall primary cancer risk in 6840 patients receiving GH as adults was not increased. Elevated SIRs (which is risk of getting cancer) were found for subgroups in the USA cohort defined by age <35 years or childhood onset GH deficiency.
The FDA issued a Safety Alert in August 2011, communicating the fact that a French study found that persons with certain kinds of short stature (idiopathic growth hormone deficiency and idiopathic or gestational short stature) treated with recombinant human growth hormone during childhood and who were followed over a long period of time, were at a small increased risk of death when compared to individuals in the general population of France.
On Dec, 09, 2016 457 people reported to have side effects when taking Norditropin Nordiflex. Among them, 2 people (0.44%) have Hallucination
On Dec, 24, 2016 2,409 people reported to have side effects when taking Norditropin.
Among them, 3 people (0.12%) have Hallucination
On Nov, 08, 2016; 444 people reported to have side effects when taking Norditropin Nordiflex. Among them, 11 people (2.48%) have Death
On Oct, 24, 2016 1,497 people reported to have side effects when taking Norditropin. Among them, 22 people (1.47%) have Death
On Oct, 28, 2016 173 people reported to have side effects when taking Norditropin Flexpro. Among them, 8 people (4.62%) have Death
